Thomas Jax

3.6k total citations · 2 hit papers
44 papers, 2.7k citations indexed

About

Thomas Jax is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Jax has authored 44 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Jax's work include Blood properties and coagulation (8 papers), Coronary Interventions and Diagnostics (8 papers) and Diabetes Treatment and Management (8 papers). Thomas Jax is often cited by papers focused on Blood properties and coagulation (8 papers), Coronary Interventions and Diagnostics (8 papers) and Diabetes Treatment and Management (8 papers). Thomas Jax collaborates with scholars based in Germany, United States and Netherlands. Thomas Jax's co-authors include Jed G. Nuchtern, Margaret A. Goodell, Malcolm K. Brenner, Gerald Wulf, U. Göbel, Angela E. Foster, Malte Kelm, Tim Heise, Karin Bergmann and R. H. A. Becker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Thomas Jax

42 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A distinct “side population” of cells with high drug efflux capacity in human tumor cells

2004 1.0k citations Thomas Jax et al. profile →
New Insulin Glargine 300 Units·mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL−1

2014 292 citations Thomas Jax, Tim Heise et al. profile →

Peers

Countries citing papers authored by Thomas Jax

Since Specialization

Citations

This map shows the geographic impact of Thomas Jax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jax more than expected).

Fields of papers citing papers by Thomas Jax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Jax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jax. The network helps show where Thomas Jax may publish in the future.

Co-authorship network of co-authors of Thomas Jax

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Jax. A scholar is included among the top collaborators of Thomas Jax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Jax. Thomas Jax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes 2017 ·Cardiovascular Diabetology ·Thomas Jax, Alin Stirban, (unknown), (unknown), (unknown), Sandra Thiemann, Robert Ćhilton, Maximilian von Eynatten, Nikolaus Marx	33
2	Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels 2015 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), J. Hans DeVries, Tim Heise, Thomas Jax	38
3	Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes 2012 ·Diabetes Research and Clinical Practice ·Michael Horowitz, Anne Flint, Karen L. Jones, Charlotte Hindsberger, Mads Frederik Rasmussen, Christoph Kapitza, Selena Doran, Thomas Jax, Milan Zdravković, Ian Chapman	144
4	Metabolic memory: a vascular perspective 2010 ·Cardiovascular Diabetology ·Thomas Jax	48
5	Evaluation of early and late postoperative flow capacity of internal thoracic artery bypass by means of stress Doppler echocardiography 2010 ·Interactive Cardiovascular and Thoracic Surgery ·R. Marx, Thomas Jax, Stefan Perings, Mira Schannwell, (unknown), H Gülker	1
6	Gene expression analysis of human red blood cells 2009 ·International Journal of Medical Sciences ·(unknown), Petra Kleinbongard, Jens Volkmer, Birgit Andrée, Malte Kelm, Thomas Jax	78
7	Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients 2009 ·Cardiovascular Diabetology ·Thomas Jax, (unknown), Gunnar Plehn, (unknown)	32
8	Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" – Not "end-stage" after all 2009 ·BMC Cardiovascular Disorders ·Thomas Jax, (unknown), Ahmed A. Khattab, M. P. Heintzen, (unknown)	6
9	Treatment of patients with diabetes with GLP-1 analogues or DPP-4- inhibitors: a hot topic for cardiologists? 2008 ·Clinical Research in Cardiology ·Thomas Jax	9
10	Long-term urokinase therapy and isovolemic hemodilution: A clinical and hemodynamic comparison in patients with refractory angina pectoris 2005 ·International Journal of Angiology ·(unknown), (unknown), Thomas Jax, (unknown), B. E. Strauer, Matthias Leschke	3
11	Altered Blood Rheology in Obstructive Sleep Apnea as a Mediator of Cardiovascular Risk 2005 ·Cardiology ·Stephan Steiner, Thomas Jax, Stefanie Evers, M. Hennersdorf, (unknown), Bodo E. Strauer	84
12	A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization 2003 ·International Journal of Cardiology ·Stefan Perings, Malte Kelm, Thomas Jax, Bodo E. Strauer	45
13	Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas 2002 ·Journal of the American College of Cardiology ·Malte Kelm, Stefan Perings, Thomas Jax, Thomas E. Lauer, F. C. Schoebel, M. P. Heintzen, Christian Perings, Bodo E. Strauer	95
14	Vineberg graft: flow reserve of bilateral implantation after 27 years 2001 ·The Annals of Thoracic Surgery ·R. Marx, Thomas Jax, Malte Kelm, F. C. Schoebel, Bodo E. Strauer	5
15	In vitro Bleeding Test with PFA-100TM—Aspects of Controlling Individual Acetylsalicylic Acid Induced Platelet Inhibition in Patients with Cardiovascular Disease 2001 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), (unknown), Thomas Jax, F. C. Schoebel, B. E. Strauer	17
16	Detection of antiischemic therapeutic effectiveness in patients with refractory angina pectoris and end-stage coronary artery disease – Long-term intermittent urokinase therapy 1998 ·Zeitschrift für Kardiologie ·F. C. Schoebel, (unknown), C.M. Schannwell, (unknown), Thomas Jax, Matthias Leschke, B. E. Strauer	1
17	Arteria thoracica interna-Bypass - Grundlagen der Dopplersonographie für die prä- und postoperative Diagnostik 1998 ·Zeitschrift für Kardiologie ·R. Marx, Thomas Jax, F. C. Schoebel, C.M. Schannwell, Gunnar Plehn, Matthias Leschke, B. E. Strauer	7
18	Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: A randomized dose-response trial 1996 ·Journal of the American College of Cardiology ·Matthias Leschke, (unknown), (unknown), (unknown), Thomas Jax, (unknown), B. E. Strauer	32
19	Chronic‐intermittent urokinase therapy in patients with end‐stage coronary artery disease and refractory angina pectoris—A pilot study 1996 ·Clinical Cardiology ·F. C. Schoebel, Matthias Leschke, Thomas Jax, (unknown), Bodo E. Strauer	10
20	Acute Myocardial Infarction With Origin of the Left Circumflex Coronary Artery from the Right (Anterior) Aortic Sinus With Retroaortic Course to the Left Atrioventricular Sulcus 1996 ·The American Journal of Cardiology ·(unknown), M. P. Heintzen, Thomas Jax, (unknown), Christian Perings, (unknown), (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact